Gem Investment Advisors’s Alpha Tau Medical DRTS Stock Holding History
Bought
Maintained
Sold
Other funds holding DRTS
BFM
AF
PC
AC
AIM
Gem Investment Advisors's DRTS Position: Q2 2026 in Review
Gem Investment Advisors increased its Alpha Tau Medical (DRTS) stake by 1,161% in Q2 2026, buying an estimated $12M and bringing the position to 1,434,476 shares worth $18M. The position accounts for 11.06% of the portfolio, ranked #3.
Gem Investment Advisors first reported a position in DRTS in Q4 2025 and has held it in 3 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.
- Gem Investment Advisors held 1,434,476 shares of Alpha Tau Medical worth $18M as of Q2 2026.
- Gem Investment Advisors bought 1,320,740 Alpha Tau Medical shares in Q2 2026, an estimated $12M.
- Alpha Tau Medical made up 11.06% of Gem Investment Advisors's portfolio in Q2 2026, its #3 holding.
- Gem Investment Advisors first reported a position in Alpha Tau Medical in Q4 2025 and has held it in 3 quarters since.
- 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.
Based on Gem Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.